4.6 Article

Favorable Response to Antigonadal Therapy for a Benign Metastasizing Leiomyoma

Journal

OBSTETRICS AND GYNECOLOGY
Volume 119, Issue 2, Pages 438-442

Publisher

LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1097/AOG.0b013e318240090e

Keywords

-

Funding

  1. NHLBI [protocol 96-H-0100]

Ask authors/readers for more resources

BACKGROUND: Benign metastasizing leiomyoma and lymphangioleiomyomatosis (LAM) both are characterized by abnormal proliferation of smooth muscle-like cells in the lung. CASE: A 32-year-old African woman with a diagnosis of LAM underwent myomectomy for uterine leiomyomas. An alternative diagnosis of benign metastasizing leiomy oma was made on repeat lung biopsy. Treatment with leuprolide acetate decreased pulmonary infiltrates and improved lung function and exercise tolerance. CONCLUSION: Accurately diagnosing benign metastasizing leiomyoma has important implications for clinical outcome. Because its clinical presentation may be misleading, immunohistochemical techniques may assist in differentiating benign metastasizing leiomyoma from LAM. This is important because, in benign metastasizing leiomyoma, reduced tumor burden and improved pulmonary function may be achieved by suppressing gonadal steroids. (Obstet Gynecol 2012;119:438-42) DOI:10.1097/AOG.0b013e318240090e

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available